New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer

被引:36
作者
Vaidya, Jayant S. [1 ]
Bulsara, Max [2 ]
Baum, Michael [1 ]
Wenz, Frederik [3 ]
Massarut, Samuele [4 ]
Pigorsch, Steffi [5 ]
Alvarado, Michael [6 ]
Douek, Michael [7 ]
Saunders, Christobel [8 ]
Flyger, Henrik [9 ]
Eiermann, Wolfgang [10 ]
Brew-Graves, Chris [1 ]
Williams, Norman R. [1 ]
Potyka, Ingrid [1 ]
Roberts, Nicholas [1 ]
Bernstein, Marcelle [11 ]
Brown, Douglas [12 ]
Sperk, Elena [3 ]
Laws, Siobhan [13 ]
Suetterlin, Marc [14 ]
Corica, Tammy [15 ]
Lundgren, Steinar [16 ,17 ]
Holmes, Dennis [18 ,19 ]
Vinante, Lorenzo [20 ]
Bozza, Fernando [21 ]
Pazos, Montserrat [22 ]
Le Blanc-Onfroy, Magali [23 ]
Gruber, Guenther [24 ]
Polkowski, Wojciech [25 ]
Dedes, Konstantin J. [26 ]
Niewald, Marcus [27 ]
Blohmer, Jens [28 ,29 ]
McReady, David [30 ]
Hoefer, Richard [31 ]
Kelemen, Pond [32 ]
Petralia, Gloria [33 ]
Falzon, Mary [34 ]
Joseph, David [15 ]
Tobias, Jeffrey S. [35 ]
机构
[1] UCL, Div Surg & Intervent Sci, London, England
[2] Univ Notre Dame, Dept Biostat, Fremantle, WA, Australia
[3] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany
[4] IRCCS, Ctr Riferimento Oncol Aviano, Dept Surg, CRO, Aviano, Italy
[5] Tech Univ Munich, Red Cross Hosp, Dept Radiat Oncol, Munich, Germany
[6] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[7] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England
[8] Univ Western Australia, Sch Surg, Perth, WA, Australia
[9] Univ Copenhagen, Dept Breast Surg, Copenhagen, Denmark
[10] Tech Univ Munich, Red Cross Hosp, Dept Gynecol & Obstet, Munich, Germany
[11] Patient Advocate & Writer, London, England
[12] Ninewells Hosp, Dept Surg, Dundee, Scotland
[13] Royal Hampshire Cty Hosp, Dept Surg, Winchester, Hants, England
[14] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Gynecol & Obstet, Berlin, Germany
[15] Sir Charles Gairdner Hosp, Dept Radiat Oncol, Perth, WA, Australia
[16] Norwegian Univ Sci & Technol NTNU, Dept Oncol, St Olavs Univ Hosp, Trondheim, Norway
[17] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Trondheim, Norway
[18] Univ Southern Calif, John Wayne Canc Inst, Los Angeles, CA USA
[19] Univ Southern Calif, Helen Rey Breast Canc Fdn, Los Angeles, CA USA
[20] Ctr Riferimento Oncol Aviano, Dept Radiat Oncol, IRCCS, Aviano, Italy
[21] IRCCS, Inst Oncol Veneto, Dept Surg, Padua, Italy
[22] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Munich, Germany
[23] Inst Cancerol Ouest, Oncol Radiotherapeute, Nantes, France
[24] Brust Zentrum Seefeld, Zurich, Switzerland
[25] Med Univ Lublin, Dept Surg Oncol, Lublin, Poland
[26] Univ Spital Zurich, Breast Ctr, Zurich, Switzerland
[27] Saarland Univ, Med Ctr, Homburg, Germany
[28] Sankt Gertrauden Krankenhaus, Berlin, Germany
[29] Charite Univ Med Berlin, Berlin, Germany
[30] Princess Margaret Canc Ctr, Toronto, ON, Canada
[31] Sentara Surg Specialists, Hampton, VA USA
[32] New York Med Coll, Ashikari Breast Ctr, New York, NY USA
[33] Univ Coll London Hosp, Dept Surg, London, England
[34] Univ Coll London Hosp, Dept Pathol, London, England
[35] Univ Coll London Hosp, Dept Clin Oncol, London, England
基金
英国医学研究理事会;
关键词
MULTICENTRICITY; IMPAIRS;
D O I
10.1038/s41416-021-01440-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The TARGIT-A trial reported risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer to be as effective as whole-breast external beam radiotherapy (EBRT). Here, we present further detailed analyses. METHODS: In total, 2298 women (>= 45 years, invasive ductal carcinoma <= 3.5 cm, cN0-N1) were randomised. We investigated the impact of tumour size, grade, ER, PgR, HER2 and lymph node status on local recurrence-free survival, and of local recurrence on distant relapse and mortality. We analysed the predictive factors for recommending supplemental EBRT after TARGIT-IORT as part of the risk-adapted approach, using regression modelling. Non-breast cancer mortality was compared between TARGIT-IORT plus EBRT vs. EBRT. RESULTS: Local recurrence-free survival was no different between TARGIT-IORT and EBRT, in every tumour subgroup. Unlike in the EBRT arm, local recurrence in the TARGIT-IORT arm was not a predictor of a higher risk of distant relapse or death. Our new predictive tool for recommending supplemental EBRT after TARGIT-IORT is at . Non-breast cancer mortality was significantly lower in the TARGIT-IORT arm, even when patients received supplemental EBRT, HR 0.38 (95% CI 0.17-0.88) P = 0.0091. CONCLUSION: TARGIT-IORT is as effective as EBRT in all subgroups. Local recurrence after TARGIT-IORT, unlike after EBRT, has a good prognosis. TARGIT-IORT might have a beneficial abscopal effect.
引用
收藏
页码:380 / 389
页数:10
相关论文
共 29 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]   Multicentricity and recurrence of breast cancer [J].
Baum, M ;
Vaidya, JS ;
Mittra, I .
LANCET, 1997, 349 (9046) :208-208
[3]   Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding [J].
Belletti, Barbara ;
Vaidya, Jayant S. ;
D'Andrea, Sara ;
Entschladen, Frank ;
Roncadin, Mario ;
Lovat, Francesca ;
Berton, Stefania ;
Perin, Tiziana ;
Candiani, Ezio ;
Reccanello, Sonia ;
Veronesi, Andrea ;
Canzonieri, Vincenzo ;
Trovo, Mauro G. ;
Zaenker, Kurt S. ;
Colombatti, Alfonso ;
Baldassarre, Gustavo ;
Massarut, Samuele .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1325-1332
[4]   Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review [J].
Chicas-Sett, Rodolfo ;
Morales-Orue, Ignacio ;
Castilla-Martinez, Juan ;
Zafra-Martin, Juan ;
Kannemann, Andrea ;
Blanco, Jesus ;
Lloret, Marta ;
Lara, Pedro C. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
[5]   Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study [J].
Cifarelli, Christopher P. ;
Brehmer, Stefanie ;
Vargo, John Austin ;
Hack, Joshua D. ;
Kahl, Klaus Henning ;
Sarria-Vargas, Gustavo ;
Giordano, Frank A. .
JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (02) :391-397
[6]  
Darby SC, 2013, NEW ENGL J MED, V368, P2527
[7]   Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) [J].
Gourgou-Bourgade, S. ;
Cameron, D. ;
Poortmans, P. ;
Asselain, B. ;
Azria, D. ;
Cardoso, F. ;
A'Hern, R. ;
Bliss, J. ;
Bogaerts, J. ;
Bonnefoi, H. ;
Brain, E. ;
Cardoso, M. J. ;
Chibaudel, B. ;
Coleman, R. ;
Cufer, T. ;
Dal Lago, L. ;
Dalenc, F. ;
De Azambuja, E. ;
Debled, M. ;
Delaloge, S. ;
Filleron, T. ;
Gligorov, J. ;
Gutowski, M. ;
Jacot, W. ;
Kirkove, C. ;
MacGrogan, G. ;
Michiels, S. ;
Negreiros, I. ;
Offersen, B. V. ;
Llorca, F. Penault ;
Pruneri, G. ;
Roche, H. ;
Russell, N. S. ;
Schmitt, F. ;
Servent, V. ;
Thuerlimann, B. ;
Untch, M. ;
van der Hage, J. A. ;
van Tienhoven, G. ;
Wildiers, H. ;
Yarnold, J. ;
Bonnetain, F. ;
Mathoulin-Pelissier, S. ;
Bellera, C. ;
Dabakuyo-Yonli, T. S. .
ANNALS OF ONCOLOGY, 2015, 26 (05) :873-879
[8]   Radiobiological aspects of intraoperative tumour-bed irradiation with low-energy X-rays (LEX-IORT) [J].
Herskind, Carsten ;
Wenz, Frederik .
TRANSLATIONAL CANCER RESEARCH, 2014, 3 (01) :3-17
[9]  
Houghton, 1999, TARGETED INTRAOPERAT
[10]   Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system [J].
Hudis, Clifford A. ;
Barlow, William E. ;
Costantino, Joseph P. ;
Gray, Robert J. ;
Pritchard, Kathleen I. ;
Chapman, Judith-Anne W. ;
Sparano, Joseph A. ;
Hunsberger, Sally ;
Enos, Rebecca A. ;
Gelber, Richard D. ;
Zujewski, Jo Anne .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :2127-2132